He Became CEO With Zero Pharmacy Experience. Here's How | Kris Fishman
Founder's Story
One in 8 Americans is now on a GLP-1 medication. That is roughly 35 million people, and it created one of the fastest-growing markets in the country almost overnight. The CEO at the center of this episode captured that wave from a company most people have never heard of, and he did it after walking into the industry with zero experience. Thirteen years later, he runs the whole thing. Kris Fishman is the CEO and President of Wells Pharmacy Network, one of the largest independent compounding pharmacies in the United States. Wells operates in the personalized medicine space, including GLP-1s, peptides, and other compounded products. Kris got there without an MBA, without industry credentials, and without knowing what a compounding pharmacy was on day one. His wife had to explain it to him.
In this episode of Founder's Story, Daniel Robbins sits down with Kris to break down how an outsider becomes the CEO. While everyone around him debated products and formulations, Kris obsessed over the one problem nobody wanted to own: orders were not getting out the door fast enough. He shares how fixing that single operational bottleneck transformed the company, how he used technology and telemedicine partnerships to scale distribution nationally, why he believes not knowing the industry was his biggest advantage, and what it cost him at home, including the seasons of his kids' childhoods he never got back while telling his wife "one more year" for thirty years. He also explains why peptides and GLP-1s became one of the biggest business trends in America and what separates the companies winning that market from the roughly 7,500 competitors chasing it. If you are a founder who feels like you do not belong in the room because you came from outside the industry, this episode is proof that outsiders see what insiders cannot.
If you are stuck debating your product while your operations quietly bleed customers, Kris shows you exactly where to look. And if you have been telling your family "one more year," this conversation will hit harder than you expect.
0:00 Introduction
0:43 What Is A Compounding Pharmacy 3:15 Why Are Peptides The Hottest Thing Right Now
5:31 Could Technology & AI Help Us Live Longer
7:17 The Challenges Kris Faces Scaling Wells Pharmacy
8:14 The Biggest Misunderstanding Around Compounding
9:47 What Helped Kris Scale Wells Pharmacy Network
11:54 Kris Wakes Up Thinking About…
13:16 What It's Like Working With Many Organizations
14:40 What Got Kris To Where He Is Today
18:04 Kris’s Personal Sacrifices On His Journey
20:14 An Unlimited Possibility Moment For Kris
21:30 Closing Thoughts
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Raw Description
<p>Daniel and <a href="https://wellsrx.com/" rel="noopener noreferrer">Kris Fishman</a> explore why compounding pharmacies are suddenly part of the national health conversation, especially as GLP-1s, peptides, and personalized medicine become mainstream. Kris breaks down what compounding actually means, why “one size fits all” medicine is being questioned, and how pharmacies like Wells step in when traditional options are unavailable or not personalized enough. The conversation also covers FDA scrutiny, peptide regulation, Big Pharma tension, operational scale, and the emotional reality of leading a fast-growing healthcare company.</p> <p>Key Discussion Points</p> <p>Kris explains that compounding pharmacies go back centuries and combine active pharmaceutical ingredients to create personalized preparations when standard retail versions do not fit a patient’s needs. <br> He breaks down why peptides became a major health trend, describing them as amino acid chains that have gained traction through wellness culture, social media, and gray-market demand. <br> Kris discusses the FDA’s review process and the importance of the upcoming PCAC meeting, where physicians and pharmacists can explain why certain peptides should be available for compounding. <br> He explains that Wells Pharmacy Network focuses on quality, testing, sterile processes, and transparency, encouraging people to research their pharmacy and understand its safety standards. <br> Kris shares that the company’s operational unlock came from improving speed, technology, and order fulfillment while maintaining strict quality control. <br> He talks about the tension with Big Pharma, especially after GLP-1 shortages, and argues compounding exists to help patients where personalized or unavailable options are needed. <br> Kris says the biggest CEO pressure is not product quality, because he trusts his team, but making sure regulators understand the data, adverse effects, and patient impact behind the products they carry. <br> He opens up about the personal cost of leadership, including missing much of his children’s lives while building the company, and the tradeoff of trying to provide a better future for them.</p> <p>Takeaways</p> <p>Personalized medicine is growing because more people are questioning whether one-size-fits-all healthcare actually serves their needs. <br> The biggest misunderstanding about compounding is safety, which is why quality controls, testing, and regulatory transparency matter. <br> Peptides are popular, but Kris warns that people should avoid gray-market options and work through qualified doctors and reputable pharmacies. <br> Scaling in healthcare requires both speed and trust, because getting products out quickly means nothing if quality is compromised. <br> Leadership can create real personal sacrifice, and Kris reflects honestly on the cost of building while raising a family.</p> <p>Closing Thoughts</p> <p>Kris Fishman’s story shows the intersection of healthcare, entrepreneurship, regulation, and personal mission. What started as an industry he did not fully understand became a calling after seeing patients and family members benefit from personalized products. This episode gives listeners a clearer picture of why compounding pharmacies matter, why peptides are everywhere, and why the future of medicine may depend on safer, smarter personalization.</p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>
Chapters (1/12)
Show Notes
One in 8 Americans is now on a GLP-1 medication. That is roughly 35 million people, and it created one of the fastest-growing markets in the country almost overnight. The CEO at the center of this episode captured that wave from a company most people have never heard of, and he did it after walking into the industry with zero experience. Thirteen years later, he runs the whole thing. Kris Fishman is the CEO and President of Wells Pharmacy Network, one of the largest independent compounding pharmacies in the United States. Wells operates in the personalized medicine space, including GLP-1s, peptides, and other compounded products. Kris got there without an MBA, without industry credentials, and without knowing what a compounding pharmacy was on day one. His wife had to explain it to him.
In this episode of Founder's Story, Daniel Robbins sits down with Kris to break down how an outsider becomes the CEO. While everyone around him debated products and formulations, Kris obsessed over the one problem nobody wanted to own: orders were not getting out the door fast enough. He shares how fixing that single operational bottleneck transformed the company, how he used technology and telemedicine partnerships to scale distribution nationally, why he believes not knowing the industry was his biggest advantage, and what it cost him at home, including the seasons of his kids' childhoods he never got back while telling his wife "one more year" for thirty years. He also explains why peptides and GLP-1s became one of the biggest business trends in America and what separates the companies winning that market from the roughly 7,500 competitors chasing it. If you are a founder who feels like you do not belong in the room because you came from outside the industry, this episode is proof that outsiders see what insiders cannot.
If you are stuck debating your product while your operations quietly bleed customers, Kris shows you exactly where to look. And if you have been telling your family "one more year," this conversation will hit harder than you expect.
0:00 Introduction
0:43 What Is A Compounding Pharmacy 3:15 Why Are Peptides The Hottest Thing Right Now
5:31 Could Technology & AI Help Us Live Longer
7:17 The Challenges Kris Faces Scaling Wells Pharmacy
8:14 The Biggest Misunderstanding Around Compounding
9:47 What Helped Kris Scale Wells Pharmacy Network
11:54 Kris Wakes Up Thinking About…
13:16 What It's Like Working With Many Organizations
14:40 What Got Kris To Where He Is Today
18:04 Kris’s Personal Sacrifices On His Journey
20:14 An Unlimited Possibility Moment For Kris
21:30 Closing Thoughts
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Raw Description
<p>Daniel and <a href="https://wellsrx.com/" rel="noopener noreferrer">Kris Fishman</a> explore why compounding pharmacies are suddenly part of the national health conversation, especially as GLP-1s, peptides, and personalized medicine become mainstream. Kris breaks down what compounding actually means, why “one size fits all” medicine is being questioned, and how pharmacies like Wells step in when traditional options are unavailable or not personalized enough. The conversation also covers FDA scrutiny, peptide regulation, Big Pharma tension, operational scale, and the emotional reality of leading a fast-growing healthcare company.</p> <p>Key Discussion Points</p> <p>Kris explains that compounding pharmacies go back centuries and combine active pharmaceutical ingredients to create personalized preparations when standard retail versions do not fit a patient’s needs. <br> He breaks down why peptides became a major health trend, describing them as amino acid chains that have gained traction through wellness culture, social media, and gray-market demand. <br> Kris discusses the FDA’s review process and the importance of the upcoming PCAC meeting, where physicians and pharmacists can explain why certain peptides should be available for compounding. <br> He explains that Wells Pharmacy Network focuses on quality, testing, sterile processes, and transparency, encouraging people to research their pharmacy and understand its safety standards. <br> Kris shares that the company’s operational unlock came from improving speed, technology, and order fulfillment while maintaining strict quality control. <br> He talks about the tension with Big Pharma, especially after GLP-1 shortages, and argues compounding exists to help patients where personalized or unavailable options are needed. <br> Kris says the biggest CEO pressure is not product quality, because he trusts his team, but making sure regulators understand the data, adverse effects, and patient impact behind the products they carry. <br> He opens up about the personal cost of leadership, including missing much of his children’s lives while building the company, and the tradeoff of trying to provide a better future for them.</p> <p>Takeaways</p> <p>Personalized medicine is growing because more people are questioning whether one-size-fits-all healthcare actually serves their needs. <br> The biggest misunderstanding about compounding is safety, which is why quality controls, testing, and regulatory transparency matter. <br> Peptides are popular, but Kris warns that people should avoid gray-market options and work through qualified doctors and reputable pharmacies. <br> Scaling in healthcare requires both speed and trust, because getting products out quickly means nothing if quality is compromised. <br> Leadership can create real personal sacrifice, and Kris reflects honestly on the cost of building while raising a family.</p> <p>Closing Thoughts</p> <p>Kris Fishman’s story shows the intersection of healthcare, entrepreneurship, regulation, and personal mission. What started as an industry he did not fully understand became a calling after seeing patients and family members benefit from personalized products. This episode gives listeners a clearer picture of why compounding pharmacies matter, why peptides are everywhere, and why the future of medicine may depend on safer, smarter personalization.</p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>